Skip to content

Comparison of the primary patency time in two diffrent kind of hemodialysis access in hemodialysis pateints

A comparison between the primary patency time of basilic vein transposition and prosthetic brachioaxillary access grafts in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101175633N1
Enrollment
60
Registered
2011-12-08
Start date
2011-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease. End-stage renal disease

Interventions

Intervention 1: Operation to create hemodialysis access for arteriovenous graft including exploration of Barachial artery and Axillary vein and pass the graft from subcutaneous area of arm and then va
including Basilic vein transposition from depth of arm to subcutaneous area and vascular anastomose with brachial artery will be done.
Treatment - Surgery
Operation to create hemodialysis access for arteriovenous graft including exploration of Barachial artery and Axillary vein and pass the graft from subcutaneous area of arm and then vascular anastomos
Operation to create hemodialysis access for Basilicvein transposition

Sponsors

Mazandaran University of Medical Sacinces Vice Chancellor of Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: suffering from end stage renal disease that candidate for long time hemodialysis but there are no chance of radio or brachiocephalic arteriovenous fistula or failure of previously existed one, no previous Basilic vein transposition or arteriovenous graft in the site of operation, No history of current medication with anticoagulants or antiplatelet agents, age 30-80 years old Exclusion criteria: anticoagulant or antiplatelet treatment after surgery and during follows up, no hemodialysis from the created access after the operation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary patency time of created dialysis access. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery. Method of measurement: No evidence of access fail or unsuccessful dialysis from the created access.

Secondary

MeasureTime frame
Presence of a palpable thrill in created access. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery. Method of measurement: a palpable thrill as well as the strength and consistency.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Pouya Tayebi

Mazandaran University of Medical Sciences

p.tayebi@yahoo.com+98 15 1225 6329

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026